Cervical cancer vaccine introduced
Jan 24, 2019 Zimbabwe becomes the eighth African country to introduce HPV vaccine into its routine immunisation programme and the eighth worldwide to do so with Gavi support. Cervical cancer is on track to overtake childbirth as the developing worlds biggest killer of women.The first dose of the HPV vaccine is routinely offered to girls aged 12 and 13 in school year 8. The second dose is normally offered 6 to 12 months after the first (in school year 8 or year 9). The HPV vaccine helps protect against cervical cancer. cervical cancer vaccine introduced
Gardasil, the First HPV Vaccine. Gardasil, the HPV vaccine made by Merck& Co. , was licensed for use in June 2006. It targets four types of HPV: 6, 11, 16 and 18. Types 16 and 18 lead to cervical cancer. HPV 6 and HPV 11 cause about 90 of genital warts. The vaccine contains a
Parth Shah, PharmD, PhD, of the Fred Hutchinson Cancer Research Center, led a discussion on the uptake challenges of the human papilloma virus (HPV) vaccine at the American Society of Clinical Jun 26, 2019 HPV infections declined substantially since a vaccine was introduced, providing 'strong evidence' the vaccine prevents cervical cancer in the real world, according to acervical cancer vaccine introduced May 02, 2018 Cervical cancer vaccine introduced in Zimbabwe. The vaccines, which will be funded by Gavi, the Vaccine Alliance and the Government of Zimbabwe, will reach over 800, 000 girls aged between 1014 years old across the country. UNICEF, WHO and partners will work alongside the Zimbabwe Ministry of Health on implementation.